Deutsche Bank AG Acquires 36,392 Shares of Amedisys, Inc. $AMED

Key Points

• Deutsche Bank AG significantly increased its stake in Amedisys, Inc. by 1,441.8% during the first quarter, acquiring a total of 38,916 shares valued at approximately $3.61 million.
• Amedisys reported a net margin of 3.56% and a revenue increase of 5.2% year-over-year, with earnings of $1.54 per share for the last quarter, exceeding analyst expectations.
• Wall Street analysts downgraded Amedisys from a "strong-buy" rating to a "buy" rating recently, reflecting a shift in market sentiment.

Deutsche Bank AG increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 1,441.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,916 shares of the health services provider's stock after buying an additional 36,392 shares during the period. Deutsche Bank AG owned 0.12% of Amedisys worth $3,605,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Wells Fargo & Company MN increased its holdings in shares of Amedisys by 4.7% in the fourth quarter. Wells Fargo & Company MN now owns 7,161 shares of the health services provider's stock valued at $650,000 after purchasing an additional 323 shares in the last quarter. Invesco Ltd. increased its stake in shares of Amedisys by 5.8% in the 4th quarter. Invesco Ltd. now owns 90,847 shares of the health services provider's stock valued at $8,248,000 after buying an additional 4,942 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Amedisys during the fourth quarter valued at $215,000. Sterling Capital Management LLC increased its position in Amedisys by 50.9% in the fourth quarter. Sterling Capital Management LLC now owns 1,922 shares of the health services provider's stock worth $174,000 after purchasing an additional 648 shares during the period. Finally, Barclays PLC lifted its position in Amedisys by 333.4% during the 4th quarter. Barclays PLC now owns 67,310 shares of the health services provider's stock valued at $6,112,000 after purchasing an additional 51,781 shares during the period. 94.36% of the stock is owned by institutional investors.

Amedisys Stock Performance

NASDAQ AMED traded up $0.03 during trading on Friday, reaching $101.01. 1,060,057 shares of the company's stock were exchanged, compared to its average volume of 780,222. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $101.02. The stock has a market capitalization of $3.32 billion, a P/E ratio of 39.30, a PEG ratio of 1.34 and a beta of 0.89. The business has a 50 day moving average price of $98.39 and a 200-day moving average price of $94.97. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.36 and a quick ratio of 1.36.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The health services provider reported $1.54 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.15. The business had revenue of $621.86 million for the quarter, compared to analyst estimates of $614.61 million. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. Amedisys's quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.98 EPS. Sell-side analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Wall Street Zen cut shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $100.50.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.